Methyl 2-(1,4-dibenzylpiperazin-2-yl)acetate

Catalog No. :
ACGFKR596
CAS No. :
183742-32-7
Molecular Formula :
C21H26N2O2
Molecular Weight :
338.45

IUPAC Name:methyl 2-(1,4-dibenzylpiperazin-2-yl)acetate

Methyl 2-(1,4-dibenzylpiperazin-2-yl)acetate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$53.00Login to see priceIn stockIn stock
5g97%$231.00Login to see priceIn stockIn stock
10g97%$439.00Login to see priceIn stockInquiry
25g97%$1065.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl 2-(1,4-dibenzylpiperazin-2-yl)acetate
IUPAC Namemethyl 2-(1,4-dibenzylpiperazin-2-yl)acetate
MDL No.MFCD00674203
Molecular FormulaC21H26N2O2
Molecular Weight338.45
SMILESO=C(OC)CC1N(CC2=CC=CC=C2)CCN(CC3=CC=CC=C3)C1
InChI KeyJCQKPXHKGNJTQQ-UHFFFAOYSA-N
Synonym(1,4-Dibenzyl-piperazin-2-yl)-acetic acid methyl ester;Methyl2-(1,4-dibenzylpiperazin-2-yl)acetate;2-Piperazineacetic acid, 1,4-bis(phenylMethyl)-, Methyl ester;1,4-dibenzyl-2-methoxycarbonylmethylpiperazine;Methyl 1,4-Dibenzylpiperazine-2-acetate
CAS No.183742-32-7
PubChem CID22710010

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACGFKR596 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACXTZM048 route compound structure diagram
    ACXTZM0486000-00-6 In Stock
  2. Plus
  3. ACDPFW387 route compound structure diagram
    ACDPFW387140-28-3 In Stock
  4. Then
  5. ACGFKR596 route product structure diagram
    ACGFKR596183742-32-7 In Stock
Inquiry

2. ACGFKR596 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACGFKR596 route product structure diagram
    ACGFKR596183742-32-7 In Stock
Inquiry

Comments (0)